Biogen Idec (BIIB) Pops on Strong Tecfidera Rx Growth
Tweet Send to a Friend
Biogen Idec (Nasdaq: BIIB) is ticking higher on the session following an update on Tecfidera (BG-12) performance.
Data out ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Data out ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


